DE60019433D1 - Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung - Google Patents

Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung

Info

Publication number
DE60019433D1
DE60019433D1 DE60019433T DE60019433T DE60019433D1 DE 60019433 D1 DE60019433 D1 DE 60019433D1 DE 60019433 T DE60019433 T DE 60019433T DE 60019433 T DE60019433 T DE 60019433T DE 60019433 D1 DE60019433 D1 DE 60019433D1
Authority
DE
Germany
Prior art keywords
ampk
coded
dna sequences
sequences therefor
gamma variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60019433T
Other languages
English (en)
Other versions
DE60019433T2 (de
Inventor
Leif Andersson
Christian Looft
Ernst Kalm
Denis Milan
Annie Robic
Claire Rogel-Gaillard
Nathalie Iannuccelli
Joel Gellin
Roy Pascale Le
Patrick Chardon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arexis AB
Original Assignee
Arexis AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arexis AB filed Critical Arexis AB
Publication of DE60019433D1 publication Critical patent/DE60019433D1/de
Application granted granted Critical
Publication of DE60019433T2 publication Critical patent/DE60019433T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60019433T 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung Expired - Lifetime DE60019433T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99402236 1999-09-10
EP99402236 1999-09-10
EP00401388 2000-05-18
EP00401388 2000-05-18
PCT/EP2000/009896 WO2001020003A2 (en) 1999-09-10 2000-09-11 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof

Publications (2)

Publication Number Publication Date
DE60019433D1 true DE60019433D1 (de) 2005-05-19
DE60019433T2 DE60019433T2 (de) 2006-02-23

Family

ID=26073491

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60019433T Expired - Lifetime DE60019433T2 (de) 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung
DE0001210441T Pending DE00967845T1 (de) 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0001210441T Pending DE00967845T1 (de) 1999-09-10 2000-09-11 Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung

Country Status (15)

Country Link
US (1) US7462693B2 (de)
EP (1) EP1210441B1 (de)
JP (2) JP3983051B2 (de)
KR (1) KR100806954B1 (de)
CN (1) CN100439503C (de)
AT (1) ATE293167T1 (de)
AU (1) AU781744B2 (de)
BR (1) BR0013890A (de)
CA (1) CA2384313C (de)
DE (2) DE60019433T2 (de)
DK (1) DK1210441T3 (de)
ES (1) ES2239618T3 (de)
MX (1) MXPA02002613A (de)
PL (1) PL354753A1 (de)
WO (1) WO2001020003A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142310A1 (en) * 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
WO2002020850A2 (en) 2000-09-08 2002-03-14 Iowa State Universtiy Research Foundation, Inc. Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
WO2003065795A2 (en) 2002-01-18 2003-08-14 Evotec Neurosciences Gmbh An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
WO2003063586A1 (en) * 2002-02-01 2003-08-07 Arexis Ab Transgenic animals expressing prkag3
US7208305B2 (en) 2002-02-01 2007-04-24 Arexis Ab Variants of the α1 subunit of human AMPK
US20050155091A1 (en) * 2002-02-01 2005-07-14 Thomas Svensson Prkag3 gene promoter and uses thereof
GB0221148D0 (en) * 2002-09-12 2002-10-23 Univ Dundee Kinase inhibitor screening assay
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
CN104894239B (zh) * 2015-05-11 2017-12-19 中国农业科学院植物保护研究所 一种用AMPKγ基因评价昆虫发育速率的方法
CN113207808B (zh) * 2021-06-03 2023-09-29 贵州大学 一种柯乐猪的选育方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104392A (en) * 1974-11-08 1978-08-01 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them
US4046876A (en) * 1974-11-08 1977-09-06 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4070457A (en) * 1974-11-08 1978-01-24 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4041156A (en) * 1974-11-08 1977-08-09 Mitsubishi Chemical Industries Limited N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4055651A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018915A (en) * 1976-01-05 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4055636A (en) * 1974-11-08 1977-10-25 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4096255A (en) * 1974-11-08 1978-06-20 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods
US4073914A (en) * 1974-11-08 1978-02-14 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4036955A (en) * 1976-07-22 1977-07-19 Mitsubishi Chemical Industries Ltd. N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018913A (en) * 1976-01-14 1977-04-19 Mitsubishi Chemical Industries Ltd. N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
AUPN745096A0 (en) * 1996-01-08 1996-02-01 St. Vincent's Institute Of Medical Research Novel amp activated protein kinase
US5885803A (en) * 1997-06-19 1999-03-23 Incyte Pharmaceuticals, Inc. Disease associated protein kinases
US20020142310A1 (en) 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
WO2002020850A2 (en) 2000-09-08 2002-03-14 Iowa State Universtiy Research Foundation, Inc. Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
WO2003063586A1 (en) 2002-02-01 2003-08-07 Arexis Ab Transgenic animals expressing prkag3
US7208305B2 (en) 2002-02-01 2007-04-24 Arexis Ab Variants of the α1 subunit of human AMPK
US20050155091A1 (en) 2002-02-01 2005-07-14 Thomas Svensson Prkag3 gene promoter and uses thereof

Also Published As

Publication number Publication date
JP3983051B2 (ja) 2007-09-26
JP2003509052A (ja) 2003-03-11
EP1210441B1 (de) 2005-04-13
BR0013890A (pt) 2002-05-07
US7462693B2 (en) 2008-12-09
DK1210441T3 (da) 2005-07-04
AU7786400A (en) 2001-04-17
CN100439503C (zh) 2008-12-03
US20070199081A1 (en) 2007-08-23
PL354753A1 (en) 2004-02-23
KR100806954B1 (ko) 2008-02-22
WO2001020003A3 (en) 2001-05-17
ATE293167T1 (de) 2005-04-15
MXPA02002613A (es) 2003-10-14
DE60019433T2 (de) 2006-02-23
CA2384313C (en) 2010-10-19
AU781744B2 (en) 2005-06-09
KR20020062918A (ko) 2002-07-31
ES2239618T3 (es) 2005-10-01
CA2384313A1 (en) 2001-03-22
JP2007190021A (ja) 2007-08-02
WO2001020003A2 (en) 2001-03-22
EP1210441A2 (de) 2002-06-05
DE00967845T1 (de) 2004-07-08
CN1402787A (zh) 2003-03-12

Similar Documents

Publication Publication Date Title
DK2333099T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
ATE359286T1 (de) Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika
EP1545545A4 (de) VERBINDUNGEN MIT DEM BICYCLO 4.2.1 NONAN-SYSTEM ZUR BEHANDLUNG VON i FLAVIVIRIDAE /i INFEKTIONEN
DE60019433D1 (de) Ampk-gamma variante, dafür kodierende dna sequenzen, und deren verwendung
MX276488B (es) Regeneracion de fluidos de tratamiento que contienen gas acido.
AP2003002934A0 (en) Use of Cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders.
WO2004048534A3 (en) Modulation of cytokine-inducible kinase expression
DE60318391D1 (de) Bakteriophagen-lysin
WO2004009024A3 (en) Modulation of protein kinase c-iota expression
DE60204755D1 (de) "3,7-diazabicyclo(3.3.0)octane und deren verwendung bei der behandlung von herzrhythmusstörungen"
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
ATE443262T1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen
ITSV20030016A1 (it) Sostanze contenenti tannini o miscele di tannini.
DZ3174A1 (fr) Composition catalytique et procédé utilisant cettecomposition.
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
WO2004053083A3 (en) Modulation of fetoprotein transcription factor expression
ITRM20030087A1 (it) Metodo, impianto e composizione chimica del fluido
ITRM20000106A0 (it) Composizione per la prevenzione e/o il trattamento di vascolopatie, che comprende propionil l-carnitina e coenzima q10.
DK1670498T3 (da) DNA, der koder for p185neu, og terapeutiske anvendelser deraf
WO2004052301A3 (en) Modulation of matrix metalloproteinase 11 expression
EE200300563A (et) Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim
WO2003105778A3 (en) PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE INHIBITORS, TYPE II BETA, WITH INHIBITORY ACTION ON ANGIOGENESIS
ITMI20030408A1 (it) Metodo per l'allungamento e/o ricostruzione di un'unghia naturale, gel e struttura di supporto per unghia per l'applicazione del metodo stesso.
AU2003280655A8 (en) Novel glycosyltransferase, nucleic acid encoding the same and method of detecting cancer tissue using the nculeic acid
ITRM20020058U1 (it) Cappette monconiformi in resina calcinabile o policarbonato per impronte o ricostruzione del perno-moncone.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition